Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Cancer Biotherapy & Radiopharmaceuticals|March 2, 2010
Biologic evaluation of a novel 188Re-labeled porphyrin in mice tumor modelHaladhar D Sarma, Tapas Das, Sharmila Banerjee, et al.
RSC Medicinal Chemistry|May 28, 2021
Formulation and clinical translation of [177Lu]Lu-trastuzumab for radioimmunotheranostics of metastatic breast cancerMohini Guleria, Rohit Sharma, Jeyachitra Amirdhanayagam, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 31, 2002
Evaluation of 90Y-DTPA and 90Y-DOTA for potential application in intra-vascular radionuclide therapyUsha Pandey, Archana Mukherjee, H D Sarma, et al.
Current Radiopharmaceuticals|December 24, 2011
Studies on efficacy of a novel 177Lu-labeled porphyrin derivative in regression of tumors in mouse modelHaladhar D Sarma, Tapas Das, Sharmila Banerjee, et al.
Anti-Cancer Agents in Medicinal Chemistry|July 27, 2017
Effect of Number of Bifunctional Chelating Agents on the Pharmacokinetics and Immunoreactivity of 177Lu-labeled Rituximab: A Systemic StudyMohini Guleria, Tapas Das, Chandan Kumar, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 21, 2010
Preparation of 177Lu-labeled oxine in lipiodol as a possible agent for therapy of hepatocellular carcinoma: a preliminary animal studySuresh Subramanian, Tapas Das, Sudipta Chakraborty, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
A novel 99mTc-labeled testosterone derivative as a potential agent for targeting androgen receptorsTapas Das, Sharmila Banerjee, Grace Samuel, et al.
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|January 18, 2013
Lutetium DOTATATE whole body scans: A novel approach for evaluation of neuroendocrine tumorsNatasha Singh, Ba Krishna, Madhusudan Vyas, et al.
Pageof 14